Search Results - "Burke, Sandra E."
-
1
Zotarolimus (ABT-578) eluting stents
Published in Advanced drug delivery reviews (03-06-2006)“…Drug-eluting stents have revolutionized the field of interventional cardiology and have provided a significant innovation for preventing coronary artery…”
Get full text
Journal Article -
2
Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats
Published in European journal of pharmacology (18-01-2002)“…Bimoclomol has been shown to increase an inducible member of the heat shock protein 70 family (HSP70) and cytoprotect in vitro. Here, we addressed whether oral…”
Get full text
Journal Article -
3
Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks
Published in European heart journal (01-04-2006)“…Aims The addition of drug elution to coronary stents plays an integral role in coronary restenosis prevention. The present study was undertaken to determine…”
Get full text
Journal Article -
4
Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression
Published in Journal of cardiovascular pharmacology (01-04-2007)“…Sirolimus (rapamycin) is an immunosuppressant used in preventing allograft rejection and in drug-eluting stents to prevent restenosis after angioplasty…”
Get full text
Journal Article -
5
Selective Antagonism of the ETA Receptor Reduces Neointimal Hyperplasia After Balloon-Induced Vascular Injury in Pigs
Published in Journal of cardiovascular pharmacology (01-07-1997)“…Balloon angioplasty has become an important intervention in clinical cardiology; however, the technique is associated with a high incidence of restenosis,…”
Get full text
Journal Article -
6
Neointimal Formation After Balloon-Induced Vascular Injury in Yucatan Minipigs is Reduced by Oral Rapamycin
Published in Journal of cardiovascular pharmacology (01-06-1999)“…Rapamycin, a macrolide antibiotic known to prevent allograft rejection, is a potent inhibitor of cell proliferation. Therefore we studied the effects of orally…”
Get full text
Journal Article -
7
Evaluation of tissue perfusion in a rat model of hind-limb muscle ischemia using dynamic contrast-enhanced magnetic resonance imaging
Published in Journal of magnetic resonance imaging (01-09-2002)“…Purpose To evaluate the feasibility of using dynamic contrast‐enhanced magnetic resonance imaging (MRI) for assessment of muscle perfusion in a rat model of…”
Get full text
Journal Article -
8
Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor
Published in Journal of cardiovascular pharmacology (01-09-1983)“…A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-13080, was studied during acute myocardial ischemia (MI) in cats. To define more clearly the…”
Get more information
Journal Article -
9
Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914)
Published in Journal of medicinal chemistry (01-10-1987)“…A series of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones was synthesized and evaluated for positive inotropic activity. Only compounds with two…”
Get full text
Journal Article -
10
Evidence for Vasoconstriction Mediated by the Endothelin-B Receptor in Domestic Swine
Published in Journal of cardiovascular pharmacology (01-06-2000)“…Endothelin-1 (ET-1), a potent vasoactive and mitogenic peptide, has been implicated in a number of cardiovascular diseases, including congestive heart failure,…”
Get full text
Journal Article -
11
Endothelin-Receptor Antagonist FR 139317 Reduces Infarct Size in a Rabbit Model When Given Before, But Not After, Coronary Artery Occlusion
Published in Journal of cardiovascular pharmacology (01-01-1997)“…SUMMARYEndothelins are potent vasoactive peptides that exist as isoforms having different affinities for two main receptor subtypes, ETA and ETB. Based on…”
Get full text
Journal Article -
12
Synthesis and biological activity of 4-(diphenylmethyl)-.alpha.-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds
Published in Journal of medicinal chemistry (01-11-1992)“…A series of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-pipe razineethanol and closely related compounds was synthesized and evaluated for cardiac and…”
Get full text
Journal Article -
13
Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model
Published in Thrombosis and haemostasis (01-02-1999)“…Catheter-directed thrombolysis has gained increasing acceptance for the treatment of patients who present with vascular occlusion; however, intravenous…”
Get more information
Journal Article -
14
Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase
Published in Journal of vascular and interventional radiology (01-11-1995)“…The purpose of this review is to provide a biochemical characterization of recombinant prourokinase (r-ProUK [ABT-187]), including a description of its…”
Get more information
Journal Article -
15
Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model
Published in Thrombosis and haemostasis (01-05-1997)“…Pro-urokinase represents an important addition to the array of thrombolytic drugs currently available for clinical use because of its high clot specificity but…”
Get more information
Journal Article -
16
Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogs
Published in Journal of medicinal chemistry (01-11-1986)“…Several N-substituted 3H-indeno[1,2-c]pyridazinones (1-23) and a benzo[h]cinnolinone (24), which were designed as rigid structural modifications of…”
Get full text
Journal Article -
17
-
18
Effects of Zotarolimus (ABT-578), Sirolimus, Paclitaxel and Dexamethasone on Cytokine Production by Human Monocytes In Vitro
Published in Blood (16-11-2005)“…Introduction: Percutaneous coronary intervention (PCI) and stenting are common therapies used to mitigate symptomatic coronary artery stenosis. These…”
Get full text
Journal Article -
19
Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation
Published in Journal of cardiovascular pharmacology (01-10-1992)“…CI-959, a cell-activation inhibitor that prevents the formation of oxygen-derived free radicals by inflammatory cells, was studied to determine its effects on…”
Get more information
Journal Article -
20
Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death
Published in Thrombosis research (01-11-1983)“…Arachidonic acid (1 mg/kg) or 9,11-azo PGH2 (35 micrograms/kg) injected intravenously into anesthetized rabbits results in sudden death characterized by a…”
Get more information
Journal Article